Search…

    Saved articles

    You have not yet added any article to your bookmarks!

    Browse articles
    Select News Languages

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    HSE to Review Friedreich's Ataxia Drug Coverage

    6 minutes ago

    1

    0

    The HSE Drugs Group will meet today to discuss the potential coverage of Skyclarys, a drug that slows Friedreich's Ataxia progression. Approximately 200 individuals in Ireland are affected by this rare neurological disease. The group previously recommended against coverage, but new reports may influence their decision, which will be finalized on August 25.
    Click here to Read more
    Prev Article
    Dublin Bus Catches Fire in Donnybrook
    Next Article
    Civil War Munition Causes Security Alert in Kildare

    Related Health Updates:

    Comments (0)

      Leave a Comment